These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Kawasaki disease shock syndrome: Unique and severe subtype of Kawasaki disease. Gamez-Gonzalez LB, Moribe-Quintero I, Cisneros-Castolo M, Varela-Ortiz J, Muñoz-Ramírez M, Garrido-García M, Yamazaki-Nakashimada M. Pediatr Int; 2018 Sep; 60(9):781-790. PubMed ID: 29888440 [Abstract] [Full Text] [Related]
4. Kawasaki disease shock syndrome: case report. Yang HF, Chen WL, Chang CN, Chen SJ, Fan HC. Paediatr Int Child Health; 2016 Feb; 36(1):76-8. PubMed ID: 25695906 [Abstract] [Full Text] [Related]
5. Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey. Cattalini M, Della Paolera S, Zunica F, Bracaglia C, Giangreco M, Verdoni L, Meini A, Sottile R, Caorsi R, Zuccotti G, Fabi M, Montin D, Meneghel A, Consolaro A, Dellepiane RM, Maggio MC, La Torre F, Marchesi A, Simonini G, Villani A, Cimaz R, Ravelli A, Taddio A, Rheumatology Study Group of the Italian Pediatric Society. Pediatr Rheumatol Online J; 2021 Mar 16; 19(1):29. PubMed ID: 33726806 [Abstract] [Full Text] [Related]
6. Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-γ as biomarkers for early recognition. Li Y, Zheng Q, Zou L, Wu J, Guo L, Teng L, Zheng R, Jung LKL, Lu M. Pediatr Rheumatol Online J; 2019 Jan 05; 17(1):1. PubMed ID: 30611297 [Abstract] [Full Text] [Related]
7. [Kawasaki disease shock syndrome: a case report]. Vieni G, Pusceddu S, Bruno I, Ragni L, Marchetti F. G Ital Cardiol (Rome); 2018 Feb 05; 19(2):111-114. PubMed ID: 29531383 [Abstract] [Full Text] [Related]
8. Characteristics of Kawasaki disease in infants younger than six months of age. Chang FY, Hwang B, Chen SJ, Lee PC, Meng CC, Lu JH. Pediatr Infect Dis J; 2006 Mar 05; 25(3):241-4. PubMed ID: 16511387 [Abstract] [Full Text] [Related]
9. Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial. Tremoulet AH, Jain S, Jaggi P, Jimenez-Fernandez S, Pancheri JM, Sun X, Kanegaye JT, Kovalchin JP, Printz BF, Ramilo O, Burns JC. Lancet; 2014 May 17; 383(9930):1731-8. PubMed ID: 24572997 [Abstract] [Full Text] [Related]
10. Clinical manifestations associated with Kawasaki disease shock syndrome in Mexican children. Gámez-González LB, Murata C, Muñoz-Ramírez M, Yamazaki-Nakashimada M. Eur J Pediatr; 2013 Mar 17; 172(3):337-42. PubMed ID: 23152158 [Abstract] [Full Text] [Related]
11. Risk factors and an early predictive model for Kawasaki disease shock syndrome in Chinese children. Zhang M, Wang C, Li Q, Wang H, Li X. Ital J Pediatr; 2024 Feb 03; 50(1):22. PubMed ID: 38310292 [Abstract] [Full Text] [Related]
12. Describing Kawasaki shock syndrome: results from a retrospective study and literature review. Taddio A, Rossi ED, Monasta L, Pastore S, Tommasini A, Lepore L, Bronzetti G, Marrani E, Mottolese BD, Simonini G, Cimaz R, Ventura A. Clin Rheumatol; 2017 Jan 03; 36(1):223-228. PubMed ID: 27230223 [Abstract] [Full Text] [Related]
13. Kawasaki disease with shock as the primary manifestation: How to distinguish from toxic shock syndrome?: A case report and literature review. Wang W, Wang H, Wang H, Cheng J. Medicine (Baltimore); 2024 Aug 02; 103(31):e39199. PubMed ID: 39093792 [Abstract] [Full Text] [Related]
14. Kawasaki disease shock syndrome complicated with bilateral lung consolidation in a child: A case report. Song Y, Wei W, Liu L, Wang Y, Shi X, Li L. Medicine (Baltimore); 2020 Jul 17; 99(29):e20998. PubMed ID: 32702840 [Abstract] [Full Text] [Related]
15. Retropharyngeal involvement in Kawasaki disease--a report of four patients with retropharyngeal edema verified by magnetic resonance imaging. Puhakka L, Saat R, Klockars T, Kajosaari L, Salo E, Nieminen T. Int J Pediatr Otorhinolaryngol; 2014 Oct 17; 78(10):1774-8. PubMed ID: 25081603 [Abstract] [Full Text] [Related]
16. Characteristics of children with Kawasaki disease requiring intensive care: 10 years' experience at a tertiary pediatric hospital. Kuo CC, Lee YS, Lin MR, Hsia SH, Chen CJ, Chiu CH, Hwang MS, Huang YC. J Microbiol Immunol Infect; 2018 Apr 17; 51(2):184-190. PubMed ID: 27591913 [Abstract] [Full Text] [Related]
17. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease. Kuo HC, Lo MH, Hsieh KS, Guo MM, Huang YH. PLoS One; 2015 Apr 17; 10(12):e0144603. PubMed ID: 26658843 [Abstract] [Full Text] [Related]
18. Infections and Kawasaki disease: implications for coronary artery outcome. Benseler SM, McCrindle BW, Silverman ED, Tyrrell PN, Wong J, Yeung RS. Pediatrics; 2005 Dec 17; 116(6):e760-6. PubMed ID: 16322132 [Abstract] [Full Text] [Related]
19. Association between left ventricular ejection fraction and Kawasaki disease shock syndrome. Qiu H, Li C, He Y, Weng F, Shi H, Pan L, Guo Y, Zhang Y, Wu R, Chu M. Cardiol Young; 2019 Feb 17; 29(2):178-184. PubMed ID: 30785384 [Abstract] [Full Text] [Related]
20. Hyponatremia Is a Feature of Kawasaki Disease Shock Syndrome: A Case-Control Study. Schuster JE, Palac HL, Innocentini N, Rowley AH, Young LT, Shulman ST. J Pediatric Infect Dis Soc; 2017 Nov 24; 6(4):386-388. PubMed ID: 28177492 [Abstract] [Full Text] [Related] Page: [Next] [New Search]